SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-117650
Filing Date
2022-11-14
Accepted
2022-11-14 07:01:55
Documents
14
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2224043d2_8k.htm   iXBRL 8-K 23793
2 EXHIBIT 99.1 tm2224043d2_ex99-1.htm EX-99.1 83299
6 GRAPHIC tm2224043d2_ex99-1img001.jpg GRAPHIC 2675
  Complete submission text file 0001104659-22-117650.txt   296451

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pmn-20221114.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmn-20221114_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmn-20221114_pre.xml EX-101.PRE 22616
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2224043d2_8k_htm.xml XML 3712
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41429 | Film No.: 221380081
SIC: 2834 Pharmaceutical Preparations